A novel mouse model for obesity, type 2 diabetes, and nonalcoholic fatty liver disease

被引：0
|
作者：
Dhar, M
Sommardahl, C
Castellani, L
Johnson, D
机构：
来源：
OBESITY RESEARCH | 2003年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A5 / A5
页数：1
相关论文
共 50 条
  • [31] Effect of nateglinide on nonalcoholic fatty liver disease as a complication in type 2 diabetes
    Matsuura, Kenichi
    Mori, Yutaka
    Itoh, Yohta
    Tajima, Naoko
    DIABETES, 2007, 56 : A555 - A555
  • [32] Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood
    Bardugo, Aya
    Bendor, Cole D.
    Zucker, Inbar
    Lutski, Miri
    Cukierman-Yaffe, Tali
    Derazne, Estela
    Mosenzon, Ofri
    Tzur, Dorit
    Beer, Zivan
    Pinhas-Hamiel, Orit
    Ben-Ami, Michal
    Fishman, Boris
    Shor, Dana Ben-Ami
    Raz, Itamar
    Afek, Arnon
    Gerstein, Hertzel C.
    Haring, Hans-Ulrich
    Tirosh, Amir
    Levi, Zohar
    Twig, Gilad
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01): : E34 - E44
  • [33] Nonalcoholic Fatty Liver Disease and Endothelial Dysfunction in Patients With Type 2 Diabetes
    Shin, Jang Yel
    Lim, Jung Soo
    Lee, Mi Young
    Chung, Choon Hee
    DIABETES, 2013, 62 : A119 - A119
  • [34] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
    Muzica, Cristina M.
    Sfarti, Catalin
    Trifan, Anca
    Zenovia, Sebastian
    Cuciureanu, Tudor
    Nastasa, Robert
    Huiban, Laura
    Cojocariu, Camelia
    Singeap, Ana-Maria
    Girleanu, Irina
    Chiriac, Stefan
    Stanciu, Carol
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [35] Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
    Birkenfeld, Andreas L.
    Shulman, Gerald I.
    HEPATOLOGY, 2014, 59 (02) : 713 - 723
  • [36] Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
    Fan, Yanbo
    Xiong, Wei
    Li, Jingjing
    Hu, Aimin
    He, Zhiwei
    Zhang, Jiawen
    Zhou, Guoyun
    Yin, Qiang
    PHARMACEUTICAL BIOLOGY, 2018, 56 (01) : 567 - 572
  • [37] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
    Chiara Saponaro
    Melania Gaggini
    Amalia Gastaldelli
    Current Diabetes Reports, 2015, 15
  • [38] Type 2 diabetes, congestive heart failure and nonalcoholic fatty liver disease
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Sprenger, Lukas
    Leiherer, Andreas
    Zanolin-Purin, Daniela
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S354 - S354
  • [39] Dapagliflozin Therapy in Type 2 Diabetes Patients with nonalcoholic Fatty Liver Disease
    Kahl, S.
    DIABETOLOGE, 2018, 14 (07): : 506 - 508
  • [40] Type 2 diabetes, congestive heart failure and nonalcoholic fatty liver disease
    Maechler, M.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Sprenger, L.
    Leiherer, A.
    Zanolin-Purin, D.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S214 - S214
12345